Neobiosis
Biotechnology ResearchView the employees at
Neobiosis-
Deborah Pollock Chief Financial Officer at Neobiosis
-
Miami Beach, Florida, United States
-
Top 1%
Trish Boyce Regenerative Biologics-
Top 5%
Zachary Goldschmidt Customer Accounts Manager at Neobiosis LLC-
Miami, Florida, United States
-
Rising Star
Ian White, Ph.D. CEO at Neobiosis - Educator in the Science of Regenerative Medicine - Longevity Thought Leader-
North Miami Beach, Florida, United States
-
Top 5%
Overview
Neobiosis, LLC is a privately owned, clinical stage, biomedical contract development and manufacturing organization (CDMO) with two production facilities in downtown Gainesville and a Research & Development laboratory located within the Sid Martin UF Innovate biotechnology Institute in Alachua, FL. The focus of Neobiosis is the isolation of tissues, cells and extracellular vesicles (EVs), with medicinal potential, from donated perinatal (birth) tissues, including umbilical cord, umbilical cord blood and amniotic fluid. The name Neobiosis ("new life") is derived from a series of experiments called Parabiosis ("living together") where it was discovered that tissues, cells and EVs from a young donor could be used to promote the healing of older individuals. Neobiosis produces innovative products from healthy, full-term births, for client organizations who wish to take biomedical products though FDA-approved clinical trials for commercialization in a global market. Neobiosis is also committed to advancing an in-house pipeline of intellectual property and biologicals for use in anti-aging and regenerative medicine.
-